相关实验视频

Updated: Jun 27, 2025

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

基于网络的方法揭示了BRCA亚型中的关键基因和三阴性乳腺癌中的化疗反应

Piyush Agrawal¹, Navami Jain², Vishaka Gopalan¹

¹Cancer Data Science Lab, National Cancer Institute, NIH, Bethesda, MD, USA.

|May 3, 2024

概括

这项研究使用PathExt工具识别了驱动乳腺癌 (BRCA) 亚型的关键基因. 这些基因比传统方法更好地了解疾病机制和潜在的药物标.

科学领域:

在瘤学瘤学.
生物信息学是一种生物信息学.
基因组学就是基因组学.

背景情况:

乳腺癌 (BRCA) 显示出显著的转录异质性,使临床治疗复杂化.
关键调解基因,而不是差异表达基因 (DEGs),可能更好地代表疾病病因和转录变化.

研究的目的:

使用基于网络的方法在四种乳腺癌亚型中识别关键调解基因.
将已识别的关键基因与常规差异表达分析的疗效进行比较.

主要方法:

将基于网络的PathExt工具应用于来自四种亚型的1,059个BRCA瘤的转录基因数据.
利用单细胞转录组分析来研究瘤微环境中的基因分布.
分析了一组三阴性乳腺癌 (TNBC) 化疗反应数据集.

主要成果:

PathExt发现了比DEGs具有更大的跨瘤一致性的关键基因,揭示了共享和亚型特定的生物过程.
鉴定出来的基因在复制BRCA相关基因和在亚型特异性细胞系中的本质性方面表现优异.
确定了特定亚型的关键基因和与TNBC化疗耐药性相关的生物过程.
提出了针对介导耐药性的关键基因的假定药物.

结论:

基于关键调解基因的网络识别提供了对乳腺癌异质性和病因学的更强有力的理解.
通过PathExt识别的关键基因对于理解亚型特定生物学和化疗耐药性至关重要.
这种方法有助于发现乳腺癌中新的治疗点和耐药性机制.

关键词:

癌症癌症癌症癌症癌症癌症系统生物学生物学基因网络基因网络

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...